Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Guest Information
Dr.Mark Lawrence Chiu
Dr.Mark Lawrence Chiu
Positions:

CSO

Company:

Tavotek Biotherapeutics

Dr. Mark Chiu has been in the pharmaceutical development industry for over 25 years and has rich experience in the R&D management of multinational pharmaceutical enterprises. He was the supervisor of multiple key R&D departments in Johnson & Johnson and Abbott, responsible for leading the early R&D of several blockbusting pharmaceutical products, for example Darzalex(Daratumumab)、Tremfya (Gesulkumab)、Remicade (Infliximab), Rybruvent (amivantamab), Teclistamab, Ciltacabtagene autoleucel, etc. before the founding of Tavotek Pharmaceuticals. Within only three years, he developed nine new molecular entities (NME) for Johnson & Johnson. He graduated with a BA Biophysics from the University of California Berkeley and Ph.D Biochemistry from the University of Illinois Urbana-Champaign.   He was a post-doctoral fellow working with two Nobel winners, was in study sections in European and United States Scientific Committees.